Functional Impairment clinical trials

Explore recruiting functional impairment clinical trials.

Recruiting functional impairment studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Functional Impairment trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Single-cell deep phenotyping of B lymphocytes to personalize immunotherapy in patients with Myasthenia Gravis: clinical trial to evaluate the efficacy and safety of Rituximab in generalized AChR-antibody positive Myasthenia Gravis

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Delayed-Treatment Controlled, Phase 2 Pilot Study of Manualized MDMA-Assisted Therapy for Young Adults with Chronic Treatment-Resistant Major Depressive Disorder

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

High-Intensity Inpatient MDMA-Assisted Psychotherapy for Treatment-Refractory Posttraumatic Stress Disorder: An Open-Label Pilot Study

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Psilocybin-Assisted Psychotherapy for Posttraumatic Stress Disorder in Military Veterans: A Pilot Feasibility Study

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

BESTOW-EXTENSION: A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients

Spain, Germany, France

Therapeutic exploratory (Phase II) EU CTIS Study details

BESTOW: A Phase 2, Multicenter, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation

Spain, France, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Functional Impairment trials by city

Functional Impairment in Toronto Functional Impairment in Vancouver Functional Impairment in Montreal Functional Impairment in Calgary Functional Impairment in Edmonton Functional Impairment in Ottawa Functional Impairment in Winnipeg Functional Impairment in Quebec City Functional Impairment in Hamilton Functional Impairment in Kitchener Functional Impairment in London Functional Impairment in Halifax Functional Impairment in New York Functional Impairment in Los Angeles Functional Impairment in Chicago Functional Impairment in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease